GlassScriptPhysician profile
William H Newman
NPI 1417916545
$409.21
in general payments reported to CMS, 2019-2025
8 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $44.14 · 2021: $25.98 · 2022: $51.87 · 2023: $46.02 · 2024: $91.83 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $115.69 | 2022-2024 | Fasenra, Breztri |
| Novartis Pharmaceuticals Corporation | $98.39 | 2023-2025 | |
| Glaxosmithkline, LLC. | $46.58 | 2020-2022 | |
| Genentech USA, INC. | $46.14 | 2024-2025 | Xolair |
| Organon LLC | $31.26 | 2025 | Vtama |
| Regeneron Healthcare Solutions, INC. | $27.77 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $25.98 | 2021 | |
| Galderma Laboratories, L.P. | $17.40 | 2025 | Nemluvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.